Based on 10 reviews
AI-generated from reviews on this page. Verify anything important with the company directly.
Challand Biosimilar Consulting has been instrumental in our biosimilar development journey. Their expertise and insights have been invaluable. The team is highly professional and responsive. We highly recommend their services for anyone in need of biosimilar consultation.
👌 Challand Biosimilar Consulting is excellent! The team provided us with valuable guidance and support throughout the entire process. Their expertise in the biosimilar field is unmatched. We are extremely satisfied with their services. 🌟
Challand Biosimilar Consulting exceeded our expectations with their exceptional services. Their expertise in the biosimilar industry is unparalleled. The team was highly responsive and provided valuable guidance in navigating complex regulatory frameworks. We highly recommend their services.
I am very happy with the services provided by Challand Biosimilar Consulting. Their professionalism and knowledge in the biosimilar industry are impressive. They have greatly helped our company in navigating the regulatory landscape. I would highly recommend them to anyone looking for biosimilar consultation.
Challand Biosimilar Consulting is a reliable and professional company. Their expertise in the biosimilar field is unparalleled. They provide comprehensive consultation services that have helped our company navigate the complex regulations and requirements. The team at Challand Biosimilar Consulting is highly knowledgeable and always available to answer any questions or concerns. We have greatly benefited from their guidance and would highly recommend their services to others.
I am very impressed with the services provided by Challand Biosimilar Consulting. Their expertise and professionalism are top-notch. They helped us navigate the complex regulatory landscape with ease. I would highly recommend them to anyone in need of biosimilar consultation.
Working with Challand Biosimilar Consulting was a great experience. Their knowledge and expertise in the biosimilar field helped us overcome challenges and achieve our goals. The team was professional and attentive throughout the process. We highly recommend their services to others.
I had a wonderful experience working with this consulting firm. They provided invaluable insights and advice that positively impacted our biosimilar development project. The team was highly skilled and responsive to our needs. I greatly appreciate their expertise and professionalism. Highly recommended!
👍 Challand Biosimilar Consulting is amazing! Their expertise and assistance in the biosimilar field is incredible. They provided us with valuable guidance and support throughout the development process. We are extremely satisfied with their services. 🌟
The consulting services we received from Challand Biosimilar were exceptional. Their expertise in the field is evident in the quality of their work. They provided valuable insights and recommendations that helped us achieve our goals. I would definitely work with them again in the future.
No news yet. This is where the business shares its own updates and press.
No photos yet. Photos shared by reviewers will show up here.
The race for pharmaceutical companies to get their biosimilar products to market has intensified as patent expiry dates for a number of top-selling biological products have passed for many and for many others draw nearer. The regulatory pathways for the approval of biosimilars are well developed and tested globally. Many countries throughout the world have established legal and regulatory pathways which allow development of biosimilar products.
However, guidelines are not prescriptive and with significant advances in the scientific and analytical techniques e.g. in the field of physicochemical characterization combined with vast experience gained by the Regulatory Agencies over years of approving biosimilar products, the clinical requirements for any product is changing with time. Furthermore, biologic products are not identical, the quality and non-clinical packages for each product are different, and the commercial objectives of each client is different.